Legacy of Excellence Digital Flipbook

Chapter 5: 2017 – 2021

The next major innovation in otolaryngology already is

Lisa E. Ishii, MD, MHS, Coordinator for Research and Quality. During Phase I of Reg-ent, the data were used primarily for Merit-Based Incentive Payment System (MIPS) reporting. However by 2020, in addition to experiencing exponential growth and supporting 184 practices and 1,244 clinicians in MIPS reporting, it developed and programmed the first Reg-ent Patient Reported Outcome Measure on Age-Related Hearing Loss, achieved Qualified Clinical Data Registry designations with the Centers for Medicare & Medicaid Services (CMS) for the fourth year, and expanded its capabilities into research and data analytics for the benefit of all members regardless of practice setting. In 2020, a partnership was finalized with OM1, leading the AAO-HNSF into Phase II of Reg-ent and allowing the Academy’s robust national registry to serve as the basis for otolaryngology clinical research, to address product surveillance, and to provide a platform with additional data sources for internal and external research endeavors in support of the AAO here: Reg-ent, the otolaryngologist designed, otolaryngologist-driven, and otolaryngologist-owned clinical registry, allows for a universe of quality and safety initiatives beyond serving as our MIPS reporting instrument.” – Al Merati, 2018-2019 President, March 2019 Bulletin

Integrated in the programs and services providing ongoing support for members in meeting the growing reporting burdens was the 5+ year investment in the AAO-HNSF clinical data registry, Reg-ent. The AAO-HNSF Clinical Data Registry Supporting in the Transition from MACRA to MIPS to MPV Year over year, since it launched in 2016, participation continued to increase in Reg-ent particularly as regulatory reporting burdens grew. Reg-ent diversified its offerings and prepared for the next phases of registry development as the clinical data in Reg-ent increased exponentially. In 2019, Reg-ent expanded its capabilities into research and data analytics for the benefit of all members regardless of practice setting. By 2019, Reg-ent participants were engaging with their data, connecting with one another via the annual Reg-ent Users Conference at the AAO-HNSF Annual Meeting & OTO Experience, and utilizing specialty measures to an ever-greater degree. “I am passionate about Reg-ent because it is one of the most important quality initiatives launched by the Foundation to date. It is the first national clinical data repository for otolaryngology head and neck data. I would like to see every member involved and part of the Reg-ent registry. It is the single best investment for our future and the future of the specialty as a whole. Reg-ent serves to define quality for the specialty,” said

HARNESSING THE POWER OF DATA

RESEARCH & CLINICAL STUDIES

PATIENT OUTCOMES

QUALITY

PUBLIC REPORTING

PRODUCT SURVEILLANCE

CONTINUING CERTIFICATION

197